Last reviewed · How we verify
Skin Care and Laser Physicians of Beverly Hills — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Platelet Rich Plasma for 4 sessions | Platelet Rich Plasma for 4 sessions | marketed | ||||
| Platelet rich plasma for 2 sessions | Platelet rich plasma for 2 sessions | marketed | Autologous cellular therapy / Regenerative medicine | Dermatology / Aesthetic Medicine |
Therapeutic area mix
- Dermatology / Aesthetic Medicine · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
Subscribe to ongoing alerts
Every new pipeline event for Skin Care and Laser Physicians of Beverly Hills:
- Skin Care and Laser Physicians of Beverly Hills pipeline updates — RSS
- Skin Care and Laser Physicians of Beverly Hills pipeline updates — Atom
- Skin Care and Laser Physicians of Beverly Hills pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Skin Care and Laser Physicians of Beverly Hills — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/skin-care-and-laser-physicians-of-beverly-hills. Accessed 2026-05-18.